Back
Dianthus Therapeutics, Inc. Stock Price Chart
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
52
DNTH
Dianthus Therapeutics, Inc.
Last Price:
$42.11
Seasonality Move:
29.51%
7 Day Trial
ALL ACCESS PASS
$
7
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is moderately bullish and DNTH is experiencing slight buying pressure.
Dianthus Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.43 | Sell |
| 20-day SMA: | 42.72 | Sell |
| 50-day SMA: | 38.02 | Buy |
| 200-day SMA: | 26.18 | Buy |
| 8-day EMA: | 42.9 | Sell |
| 20-day EMA: | 41.96 | Buy |
| 50-day EMA: | 38.68 | Buy |
| 200-day EMA: | 29.79 | Buy |
Dianthus Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.49 | Buy |
| Relative Strength Index (14 RSI): | 54.38 | Buy |
| Chaikin Money Flow: | 22131 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.73 - 44.27) | Buy |
| Bollinger Bands (100): | (25.03 - 40.89) | Buy |
Dianthus Therapeutics, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Dianthus Therapeutics, Inc. Stock
Is Dianthus Therapeutics, Inc. Stock a Buy?
-
Dianthus Therapeutics, Inc. share price is 42.13 while DNTH 8-day simple moving average is 43.43, which is a Sell signal.
-
The stock price of DNTH is 42.13 while Dianthus Therapeutics, Inc. 20-day SMA is 42.72, which makes it a Sell.
-
Dianthus Therapeutics, Inc. 50-day simple moving average is 38.02 while DNTH share price is 42.13, making it a Buy technically.
-
DNTH stock price is 42.13 and Dianthus Therapeutics, Inc. 200-day simple moving average is 26.18, creating a Buy signal.
DNTH Technical Analysis vs Fundamental Analysis
Buy
52
Dianthus Therapeutics, Inc. (DNTH)
is a Buy
Is Dianthus Therapeutics, Inc. a Buy or a Sell?
-
Dianthus Therapeutics, Inc. stock is rated a BuyThe current Dianthus Therapeutics, Inc. [DNTH] share price is $42.13. The Score for DNTH is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Dianthus Therapeutics, Inc. Stock Info
Market Cap:
1.8B
Price in USD:
42.13
Share Volume:
520.2K
Dianthus Therapeutics, Inc. 52-Week Range
52-Week High:
45.46
52-Week Low:
13.37
Buy
52
Dianthus Therapeutics, Inc. (DNTH)
is a Buy
Dianthus Therapeutics, Inc. Share Price Forecast
-
What is the Dianthus Therapeutics, Inc. stock price today?The Dianthus Therapeutics, Inc. stock price is 42.13 USD today.
-
Will DNTH stock go up or go down?Dianthus Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Dianthus Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Dianthus Therapeutics, Inc. is not overvalued.
Is Dianthus Therapeutics, Inc. Stock a Buy?
-
Dianthus Therapeutics, Inc. share price is 42.13 while DNTH 8-day exponential moving average is 42.90, which is a Sell signal.
-
The stock price of DNTH is 42.13 while Dianthus Therapeutics, Inc. 20-day EMA is 41.96, which makes it a Buy.
-
Dianthus Therapeutics, Inc. 50-day exponential moving average is 38.68 while DNTH share price is 42.13, making it a Buy technically.
-
DNTH stock price is 42.13 and Dianthus Therapeutics, Inc. 200-day simple moving average is 29.79, creating a Buy signal.
Fundamental Analysis of Dianthus Therapeutics, Inc.
Is Dianthus Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.47 per share, and a decrease next year of $0.13 per share.
Technical Analysis of Dianthus Therapeutics, Inc.
Should I short Dianthus Therapeutics, Inc. stock?
-
DNTH Moving Average Covergence Divergence (MACD) indicator is 1.49, suggesting Dianthus Therapeutics, Inc. is a Buy
-
Dianthus Therapeutics, Inc. Relative Strength Index (RSI) is 54.38, which suggest Dianthus Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Dianthus Therapeutics, Inc. is (38.73 - 44.27), which suggest Dianthus Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Dianthus Therapeutics, Inc. is (25.03 - 40.89), which suggest Dianthus Therapeutics, Inc. is a Buy
* Dianthus Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.